Imirestat

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameImirestat
Drug Alias NameImirestatum咪瑞司他AL-01576Hoe-843AL01576 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlcon
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A